| Name | Title | Contact Details |
|---|
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Since 1996, Principals of Clearwater Living have been actively engaged in the ownership, operation, and development of high-quality senior living communities nationwide. More specifically, the Principals of Clearwater have been an integral part of creating various senior living platforms for operators as part of senior management. In 2011, Clearwater Living was formed for the sole purpose of providing entitled land and developing senior living communities for operators and their financial stakeholders. By combining best practices learned and aligning with top-of-class industry professionals, Clearwater Living`s primary objective is to expedite the process of supplying innovative projects to meet the growing demand of active adult and senior living communities. To further that goal, Clearwater Living and Berkshire Group entered into a joint venture in 2016. Through the joint venture, Clearwater Living will strategically acquire, develop and operate a full range of senior housing communities (including a mix of active adult, independent living, assisted living and memory care) throughout the Western United States. CWL is comprised of a high-performance real estate team utilizing our collective imagination, ingenuity and inventiveness in everything we do. Our passion is to create and manage high-quality senior living communities uniquely positioned and designed to complement their community and neighborhood culture.
Dci Biologicals Wichita Falls is a Wichita Falls, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New Chapter, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New Chapter, Inc. is based in Brattleboro, VT. You can find more information on New Chapter, Inc. at www.new-chapter.com
Healthcare Prncipals Group LLC is a Beaufort, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.